DEF 14AThe Ballot
Prelude Therapeutics Inc files DEF 14A
Filed Apr 29, 2022 · 4y ago · Accession 0001564590-22-016626
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Prelude Therapeutics Inc
- Ticker
- PRLD
- CIK
- 1678660
- Form type
- DEF 14A
- Filing date
- Apr 29, 2022
- Report date
- Jun 17, 2022
- Document
- prld-def14a_20220617.htm
- Size
- 2.0 MB